These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1890760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial.
    Avgerinos A, Rekoumis G, Klonis C, Papadimitriou N, Gouma P, Pournaras S, Raptis S.
    J Hepatol; 1993 Sep; 19(2):301-11. PubMed ID: 8301065
    [Abstract] [Full Text] [Related]

  • 6. Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial.
    Ink O, Martin T, Poynard T, Reville M, Anciaux ML, Lenoir C, Marill JL, Labadie H, Masliah C, Perrin D.
    Hepatology; 1992 Oct; 16(4):912-9. PubMed ID: 1398497
    [Abstract] [Full Text] [Related]

  • 7. A controlled trial of oral propranolol compared with injection sclerotherapy for the long-term management of variceal bleeding.
    Westaby D, Polson RJ, Gimson AE, Hayes PC, Hayllar K, Williams R.
    Hepatology; 1990 Mar; 11(3):353-9. PubMed ID: 2179096
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions.
    Lundell L, Leth R, Lind T, Lönroth H, Sjövall M, Olbe L.
    Acta Chir Scand; 1990 Oct; 156(10):711-5. PubMed ID: 2264429
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study].
    Dollet JM, Champigneulle B, Patris A, Bigard MA, Gaucher P.
    Gastroenterol Clin Biol; 1988 Mar; 12(3):234-9. PubMed ID: 3259521
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration.
    Vinel JP, Lamouliatte H, Cales P, Combis JM, Roux D, Desmorat H, Pradere B, Barjonet G, Quinton A.
    Gastroenterology; 1992 May; 102(5):1760-3. PubMed ID: 1568586
    [Abstract] [Full Text] [Related]

  • 18. A prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy.
    Acharya SK, Dasarathy S, Saksena S, Pande JN.
    J Hepatol; 1993 Sep; 19(2):291-300. PubMed ID: 8301064
    [Abstract] [Full Text] [Related]

  • 19. Prophylaxis of first hemorrhage from esophageal varices by sclerotherapy, propranolol or both in cirrhotic patients: a randomized multicenter trial. The PROVA Study Group.
    Hepatology; 1991 Dec; 14(6):1016-24. PubMed ID: 1959848
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.